Get the Stockscreener App
131.54
3.13%
-4.25
Pre-market:
130.60
-0.94
-0.71%
Transmedics Group Inc stock is traded at $131.54, with a volume of 1.35M.
It is down -3.13% in the last 24 hours and up +17.24% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$135.79
Open:
$135.67
24h Volume:
1.35M
Relative Volume:
1.28
Market Cap:
$4.48B
Revenue:
$531.29M
Net Income/Loss:
$71.66M
P/E Ratio:
68.02
EPS:
1.9338
Net Cash Flow:
$17.35M
1W Performance:
+0.78%
1M Performance:
+17.24%
6M Performance:
+42.96%
1Y Performance:
+60.47%
1-Day Range:
$127.51
$140.87
1-Week Range:
$120.80
$140.87
52-Week Range:
$55.00
$145.50
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
131.54 | 4.64B | 531.29M | 71.66M | 17.35M | 1.9338 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Upgrade | Needham | Hold → Buy |
| Oct-13-25 | Initiated | Jefferies | Buy |
| Sep-16-25 | Initiated | Evercore ISI | Outperform |
| Sep-04-25 | Initiated | Stifel | Hold |
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-22-24 | Downgrade | Needham | Buy → Hold |
| Oct-29-24 | Reiterated | Needham | Buy |
| Oct-29-24 | Reiterated | Oppenheimer | Outperform |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Aug-21-24 | Initiated | Needham | Buy |
| Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-24 | Initiated | Stephens | Overweight |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
How TransMedics Group Inc. stock responds to policy changesQuarterly Portfolio Review & Entry Point Confirmation Signals - newser.com
Will TransMedics Group Inc. stock outperform value stocksStock Surge & Weekly Sector Rotation Insights - newser.com
Published on: 2025-11-02 22:23:53 - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is TransMedics Group Inc. stock overvalued by current metricsMarket Activity Recap & Free Daily Entry Point Trade Alerts - newser.com
TransMedics Group Inc. stock trendline breakdown2025 Trading Volume Trends & Weekly Top Gainers Alerts - newser.com
Spire Wealth Management Makes New $679,000 Investment in TransMedics Group, Inc. $TMDX - MarketBeat
Can TransMedics Group Inc. rally from current levels2025 Short Interest & High Return Trade Guides - newser.com
Technical signs of recovery in TransMedics Group Inc.2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
TransMedics Group’s Earnings Call Highlights Robust Growth and Strategic Expansion - MSN
Edward Basile Sells 4,142 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
What candlestick patterns are forming on TransMedics Group Inc.Swing Trade & Free Expert Verified Stock Movement Alerts - newser.com
How TransMedics Group Inc. stock performs in rate cut cycles2025 Technical Patterns & AI Driven Price Predictions - newser.com
Why TransMedics Group Inc. stock is trending among retail traders2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com
What institutional flow reveals about TransMedics Group Inc.July 2025 Market Mood & Low Drawdown Investment Strategies - newser.com
Can TransMedics Group Inc. stock hit analyst price targetsTrade Signal Summary & Free Real-Time Market Sentiment Alerts - newser.com
Chart overlay techniques for tracking TransMedics Group Inc.July 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
TransMedics Group, Inc. (NASDAQ:TMDX) Q3 2025 Earnings Call Transcript - MSN
Retail Traders Swarm TransMedics After Q3 Print— Retail Bulls Call It A ‘Hardcore Dip Buy’ - Stocktwits
TransMedics director exercises 4,142 options, sells shares same day - Stock Titan
Operating cash flow per share of TransMedics Group, Inc. – BX:TMDX - TradingView
TransMedics Group, Inc. (TMDX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
TransMedics (NASDAQ: TMDX) grants options at $132.45 exercise price to 15 - Stock Titan
TransMedics: Growth Tailwinds Should Provide Upside In 2026 (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group, Inc. $TMDX Shares Sold by Emerald Mutual Fund Advisers Trust - MarketBeat
TransMedics Group (NASDAQ:TMDX) Price Target Cut to $140.00 by Analysts at Piper Sandler - MarketBeat
Here's Why TransMedics (TMDX) is a Strong Growth Stock - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG), TransMedics Group (TMDX) and Arcus Biosciences (RCUS) - The Globe and Mail
Should you wait for a breakout in TransMedics Group Inc.Quarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), TransMedics Group (TMDX) and Opko Health (OPK) - The Globe and Mail
TransMedics Group (TMDX): Assessing Valuation After Strong Q3 Results and Upgraded Growth Outlook - Yahoo Finance
Analysts Are Bullish on Top Healthcare Stocks: TransMedics Group (TMDX), Nuvalent (NUVL) - The Globe and Mail
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Sahm
What MACD signals say about TransMedics Group Inc.Trade Risk Summary & Technical Pattern Based Signals - newser.com
Detecting support and resistance levels for TransMedics Group Inc.Watch List & Fast Gaining Stock Strategy Reports - newser.com
TransMedics (TMDX) Net Profit Margin Doubles, Reinforcing Bullish Momentum Narratives - Yahoo Finance
TransMedics Group Reports Strong Q3 2025 Results - MSN
TransMedics Group, Inc. (TMDX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
TransMedics Group Inc (TMDX) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
TransMedics Group (NASDAQ:TMDX) Issues Earnings Results - MarketBeat
TransMedics Group Inc (TMDX) Q3 2025 Earnings Call Highlights: R - GuruFocus
TMDX Stock Falls Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y - Yahoo Finance
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TransMedics Group revenue up 32% to USD 143.8M in Q3 2025 - Medical Buyer
Canaccord Genuity Maintains TransMedics Group (TMDX) Buy Recommendation - Nasdaq
TransMedics: Q3 Results Disappointed, As Expected (Rating Upgrade) (NASDAQ:TMDX) - Seeking Alpha
Has TransMedics Group Rallied Too Far After FDA Approval in 2025? - Yahoo Finance
TransMedics Group (TMDX): Canaccord Genuity Raises Price Target - GuruFocus
Piper Sandler Lowers Price Target on TMDX, Maintains Overweight - GuruFocus
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
14.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):